First Trust Advisors LP Roivant Sciences Ltd. Transaction History

First Trust Advisors LP

$127 Billion
Q3 2025

A detailed history of First Trust Advisors LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, First Trust Advisors LP holds 16,157 shares of ROIV stock, worth $327,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,157

Previous 18,515 12.74%

Holding current value

$327,825

Previous $208,000 17.31%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$10.74 - $15.28 $25,324 - $36,030	-2,358 Reduced 12.74%	16,157 $244,000
Q2 2025 Aug 13, 2025	SELL	$9.08 - $11.62 $19.2 Million - $24.6 Million	-2,119,679 Reduced 99.13%	18,515 $208,000
Q1 2025 May 14, 2025	SELL	$10.09 - $12.08 $3.1 Million - $3.71 Million	-307,202 Reduced 12.56%	2,138,194 $21.6 Million
Q4 2024 Feb 13, 2025	SELL	$11.16 - $12.71 $6.26 Million - $7.13 Million	-561,219 Reduced 18.67%	2,445,396 $28.9 Million
Q3 2024 Nov 13, 2024	SELL	$10.17 - $12.5 $5,359 - $6,587	-527 Reduced 0.02%	3,006,615 $34.7 Million
Q2 2024 Aug 13, 2024	BUY	$10.36 - $11.74 $13.4 Million - $15.2 Million	1,290,584 Added 75.18%	3,007,142 $31.8 Million
Q1 2024 May 13, 2024	SELL	$9.87 - $11.8 $10.1 Million - $12.1 Million	-1,022,880 Reduced 37.34%	1,716,558 $18.1 Million
Q4 2023 Feb 13, 2024	BUY	$8.38 - $11.58 $18.7 Million - $25.8 Million	2,227,192 Added 434.79%	2,739,438 $30.8 Million
Q3 2023 Nov 13, 2023	BUY	$9.76 - $13.19 $3.28 Million - $4.44 Million	336,331 Added 191.19%	512,246 $5.98 Million
Q2 2023 Aug 14, 2023	SELL	$7.09 - $10.08 $557,139 - $792,096	-78,581 Reduced 30.88%	175,915 $1.77 Million
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $1.76 Million - $2.54 Million	254,496 New	254,496 $1.88 Million

Others Institutions Holding ROIV

# of Institutions

373

Shares Held

436M

Call Options Held

6.05M

Put Options Held

2.52M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $14.3B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Roivant Sciences Ltd. Transaction History